James F. Zawada, Ph.D.
Affiliations: | 2004 | Stanford University, Palo Alto, CA |
Area:
Chemical EngineeringGoogle:
"James Zawada"Parents
Sign in to add mentorJames R. Swartz | grad student | 2004 | Stanford | |
(Scale-up, optimization, and analysis of Escherichia coli extracts for cell -free protein synthesis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hanson J, Groff D, Carlos A, et al. (2023) An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates. Bioengineering (Basel, Switzerland). 10 |
Zawada JF, Burgenson D, Yin G, et al. (2022) Cell-free technologies for biopharmaceutical research and production. Current Opinion in Biotechnology. 76: 102719 |
Abrahams C, Krimm S, Li X, et al. (2019) Abstract NT-090: PRECLINICAL ACTIVITY AND SAFETY OF STRO-002, A NOVEL ADC TARGETING FOLATE RECEPTOR ALPHA FOR OVARIAN AND ENDOMETRIAL CANCER Clinical Cancer Research. 25 |
Solis W, Almeida VD, Yu A, et al. (2018) Abstract 742: Nonclinical safety evaluation of STRO-001, a site-specific anti-CD74 antibody-drug conjugate for the potential treatment of B-cell malignancies Cancer Research. 78: 742-742 |
Li X, Abrahams C, Zhou S, et al. (2018) Abstract 1782: Discovery and activity of STRO-002, a novel ADC targeting folate receptor alpha for ovarian and endometrial cancer Cancer Research. 78: 1782-1782 |
Abrahams C, Li X, DeAlmeida V, et al. (2017) Abstract 67: Characterization and preclinical development of STRO-001, a novel CD74-targeting antibody-drug conjugate (ADC) for the treatment of B-cell malignancies Cancer Research. 77: 67-67 |
Li X, Abrahams C, Embry M, et al. (2016) Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL) Blood. 128: 464-464 |
Abrahams C, Li X, Yu A, et al. (2016) Discovery and Preclinical Development of Novel CD74-Targeting Antibody-Drug Conjugates (ADCs) with Significant Activity in Multiple Myeloma (MM) Cell Lines and Xenograft Models Blood. 128: 4465-4465 |
Cai Q, Hanson JA, Steiner AR, et al. (2015) A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell-free protein synthesis systems. Biotechnology Progress. 31: 823-31 |
Yin G, Garces ED, Yang J, et al. (2012) Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system. Mabs. 4: 217-25 |